211 related articles for article (PubMed ID: 18412986)
1. The vitamin D receptor in cancer.
Thorne J; Campbell MJ
Proc Nutr Soc; 2008 May; 67(2):115-27. PubMed ID: 18412986
[TBL] [Abstract][Full Text] [Related]
2. Targets of vitamin D receptor signaling in the mammary gland.
Welsh J
J Bone Miner Res; 2007 Dec; 22 Suppl 2():V86-90. PubMed ID: 18290729
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D and prevention of breast cancer.
Welsh J
Acta Pharmacol Sin; 2007 Sep; 28(9):1373-82. PubMed ID: 17723171
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic corruption of VDR signalling in malignancy.
Abedin SA; Banwell CM; Colston KW; Carlberg C; Campbell MJ
Anticancer Res; 2006; 26(4A):2557-66. PubMed ID: 16886664
[TBL] [Abstract][Full Text] [Related]
5. The vitamin D receptor as a therapeutic target.
Campbell MJ; Adorini L
Expert Opin Ther Targets; 2006 Oct; 10(5):735-48. PubMed ID: 16981830
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic applications for novel non-hypercalcemic vitamin D receptor ligands.
Choi M; Makishima M
Expert Opin Ther Pat; 2009 May; 19(5):593-606. PubMed ID: 19441936
[TBL] [Abstract][Full Text] [Related]
7. Breast cancer cell regulation by high-dose Vitamin D compounds in the absence of nuclear vitamin D receptor.
Valrance ME; Welsh J
J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):221-5. PubMed ID: 15225775
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D resistance.
Bouillon R; Verstuyf A; Mathieu C; Van Cromphaut S; Masuyama R; Dehaes P; Carmeliet G
Best Pract Res Clin Endocrinol Metab; 2006 Dec; 20(4):627-45. PubMed ID: 17161336
[TBL] [Abstract][Full Text] [Related]
9. Increased apoptosis of periprostatic adipose tissue in VDR null mice.
Guzey M; Jukic D; Arlotti J; Acquafondata M; Dhir R; Getzenberg RH
J Cell Biochem; 2004 Sep; 93(1):133-41. PubMed ID: 15352170
[TBL] [Abstract][Full Text] [Related]
10. RRR-alpha-vitamin E succinate potentiates the antitumor effect of calcitriol in prostate cancer without overt side effects.
Yin Y; Ni J; Chen M; Guo Y; Yeh S
Clin Cancer Res; 2009 Jan; 15(1):190-200. PubMed ID: 19118046
[TBL] [Abstract][Full Text] [Related]
11. Structure-based design of a superagonist ligand for the vitamin D nuclear receptor.
Hourai S; Rodrigues LC; Antony P; Reina-San-Martin B; Ciesielski F; Magnier BC; Schoonjans K; Mouriño A; Rochel N; Moras D
Chem Biol; 2008 Apr; 15(4):383-92. PubMed ID: 18420145
[TBL] [Abstract][Full Text] [Related]
12. The classic receptor for 1alpha,25-dihydroxy vitamin D3 is required for non-genomic actions of 1alpha,25-dihydroxy vitamin D3 in osteosarcoma cells.
Bravo S; Paredes R; Izaurieta P; Lian JB; Stein JL; Stein GS; Hinrichs MV; Olate J; Aguayo LG; Montecino M
J Cell Biochem; 2006 Nov; 99(4):995-1000. PubMed ID: 16927375
[TBL] [Abstract][Full Text] [Related]
13. Vitamin D receptor modulates the neoplastic phenotype through antagonistic growth regulatory signals.
Xu H; McCann M; Zhang Z; Posner GH; Bingham V; El-Tanani M; Campbell FC
Mol Carcinog; 2009 Aug; 48(8):758-72. PubMed ID: 19184984
[TBL] [Abstract][Full Text] [Related]
14. [VDR knockout mice and bone mineralization disorders].
Takeyama K; Yamamoto Y; Kato S
Clin Calcium; 2007 Oct; 17(10):1560-6. PubMed ID: 17906409
[TBL] [Abstract][Full Text] [Related]
15. Vitamin D receptor: molecular signaling and actions of nutritional ligands in disease prevention.
Haussler MR; Haussler CA; Bartik L; Whitfield GK; Hsieh JC; Slater S; Jurutka PW
Nutr Rev; 2008 Oct; 66(10 Suppl 2):S98-112. PubMed ID: 18844852
[TBL] [Abstract][Full Text] [Related]
16. The role of vitamin D and VDR in carcinogenesis: Through epidemiology and basic sciences.
Bandera Merchan B; Morcillo S; Martin-Nuñez G; Tinahones FJ; Macías-González M
J Steroid Biochem Mol Biol; 2017 Mar; 167():203-218. PubMed ID: 27913313
[TBL] [Abstract][Full Text] [Related]
17. Role of vitamin D receptor in the lithocholic acid-mediated CYP3A induction in vitro and in vivo.
Matsubara T; Yoshinari K; Aoyama K; Sugawara M; Sekiya Y; Nagata K; Yamazoe Y
Drug Metab Dispos; 2008 Oct; 36(10):2058-63. PubMed ID: 18645036
[TBL] [Abstract][Full Text] [Related]
18. Intervention in autoimmunity: the potential of vitamin D receptor agonists.
Adorini L
Cell Immunol; 2005 Feb; 233(2):115-24. PubMed ID: 15936743
[TBL] [Abstract][Full Text] [Related]
19. Cross-talk between vitamin D receptor (VDR)- and peroxisome proliferator-activated receptor (PPAR)-signaling in melanoma cells.
Sertznig P; Dunlop T; Seifert M; Tilgen W; Reichrath J
Anticancer Res; 2009 Sep; 29(9):3647-58. PubMed ID: 19667161
[TBL] [Abstract][Full Text] [Related]
20. UV radiation and cancer prevention: what is the evidence?
Krause R; Matulla-Nolte B; Essers M; Brown A; Hopfenmüller W
Anticancer Res; 2006; 26(4A):2723-7. PubMed ID: 16886683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]